Adobe doesn’t have a huge stake in AR (augmented reality) software or tools, but its AR tools, Aero, are a fun way to ...

Researchers in Purdue’s College of Science have created a program named NuFold, which will help progress RNA research by over ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...

MSI, the world-leading gaming and creator laptop brand, today announced its groundbreaking RTX 50 Series laptops at MSIology: ...

D Investment Partners Pte. Ltd., the asset management company of the 3D OPPORTUNITY MASTER FUND (collectively referred to as “3D,” “we” or “our”), to ...

The company uses an enormous 3D-printing robot to mass-produce "living seawalls" designed to mimic mangroves and coral reefs.

Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today ...

The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...

Net revenue and EPS results HP Inc. and its subsidiaries (“HP”) announced fiscal 2025 first quarter net revenue of $13.5 billion, up 2.4% (up 3.3% in constant currency) from the prior-year period.

The London Company Mid Cap portfolio declined 1.8% during the quarter vs. a 0.6% increase in the Russell Midcap Index.

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, ...

Ginkgo Bioworks Holdings, Inc. ( NYSE: DNA) Q4 2024 Earnings Conference Call February 25, 2025 5:30 PM ET Joseph Fridman - Director, Communications and Corporate Affairs Jason Kelly - Founder, CEO & ...